United States Erythropoietin Drugs Market Report 2016

November 2016 | 95 pages | ID: U7A7ACD5E69EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Erythropoietin Drugs

Revenue, means the sales value of Erythropoietin Drugs

This report studies sales (consumption) of Erythropoietin Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Amgen
• LG Life Sciences
• Roche
• Kyowa Hakko Kirin
• Shenyang 3SBio Inc.
• Shanghai Kirin Kunpeng
• Beijing Four Rings Biopharmaceutical
• Scipregen
• Shandong Kexing
• Company ten

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Erythropoietin Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Erythropoietin Drugs Market Report 2016

1 ERYTHROPOIETIN DRUGS OVERVIEW

1.1 Product Overview and Scope of Erythropoietin Drugs
1.2 Classification of Erythropoietin Drugs
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Erythropoietin Drugs
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Erythropoietin Drugs (2011-2021)
  1.4.1 United States Erythropoietin Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Erythropoietin Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES ERYTHROPOIETIN DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Erythropoietin Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Erythropoietin Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Erythropoietin Drugs Average Price by Manufactures (2015 and 2016)
2.4 Erythropoietin Drugs Market Competitive Situation and Trends
  2.4.1 Erythropoietin Drugs Market Concentration Rate
  2.4.2 Erythropoietin Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ERYTHROPOIETIN DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Erythropoietin Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Erythropoietin Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Erythropoietin Drugs Price by Type (2011-2016)
3.4 United States Erythropoietin Drugs Sales Growth Rate by Type (2011-2016)

4 UNITED STATES ERYTHROPOIETIN DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Erythropoietin Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Erythropoietin Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES ERYTHROPOIETIN DRUGS MANUFACTURERS PROFILES/ANALYSIS

5.1 Amgen
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Erythropoietin Drugs Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Amgen Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 LG Life Sciences
  5.2.2 Erythropoietin Drugs Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 LG Life Sciences Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Roche
  5.3.2 Erythropoietin Drugs Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Roche Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Kyowa Hakko Kirin
  5.4.2 Erythropoietin Drugs Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Kyowa Hakko Kirin Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Shenyang 3SBio Inc.
  5.5.2 Erythropoietin Drugs Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Shenyang 3SBio Inc. Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Shanghai Kirin Kunpeng
  5.6.2 Erythropoietin Drugs Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Shanghai Kirin Kunpeng Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Beijing Four Rings Biopharmaceutical
  5.7.2 Erythropoietin Drugs Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Beijing Four Rings Biopharmaceutical Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Scipregen
  5.8.2 Erythropoietin Drugs Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Scipregen Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Shandong Kexing
  5.9.2 Erythropoietin Drugs Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Shandong Kexing Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Company ten
  5.10.2 Erythropoietin Drugs Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Company ten Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 ERYTHROPOIETIN DRUGS MANUFACTURING COST ANALYSIS

6.1 Erythropoietin Drugs Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Erythropoietin Drugs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Erythropoietin Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Erythropoietin Drugs Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES ERYTHROPOIETIN DRUGS MARKET FORECAST (2016-2021)

10.1 United States Erythropoietin Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Erythropoietin Drugs Sales Forecast by Type (2016-2021)
10.3 United States Erythropoietin Drugs Sales Forecast by Application (2016-2021)
10.4 Erythropoietin Drugs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Erythropoietin Drugs
Table Classification of Erythropoietin Drugs
Figure United States Sales Market Share of Erythropoietin Drugs by Type in 2015
Table Application of Erythropoietin Drugs
Figure United States Sales Market Share of Erythropoietin Drugs by Application in 2015
Figure United States Erythropoietin Drugs Sales and Growth Rate (2011-2021)
Figure United States Erythropoietin Drugs Revenue and Growth Rate (2011-2021)
Table United States Erythropoietin Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Erythropoietin Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Erythropoietin Drugs Sales Share by Manufacturers
Figure 2016 Erythropoietin Drugs Sales Share by Manufacturers
Table United States Erythropoietin Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Erythropoietin Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Erythropoietin Drugs Revenue Share by Manufacturers
Table 2016 United States Erythropoietin Drugs Revenue Share by Manufacturers
Table United States Market Erythropoietin Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Erythropoietin Drugs Average Price of Key Manufacturers in 2015
Figure Erythropoietin Drugs Market Share of Top 3 Manufacturers
Figure Erythropoietin Drugs Market Share of Top 5 Manufacturers
Table United States Erythropoietin Drugs Sales by Type (2011-2016)
Table United States Erythropoietin Drugs Sales Share by Type (2011-2016)
Figure United States Erythropoietin Drugs Sales Market Share by Type in 2015
Table United States Erythropoietin Drugs Revenue and Market Share by Type (2011-2016)
Table United States Erythropoietin Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Erythropoietin Drugs by Type (2011-2016)
Table United States Erythropoietin Drugs Price by Type (2011-2016)
Figure United States Erythropoietin Drugs Sales Growth Rate by Type (2011-2016)
Table United States Erythropoietin Drugs Sales by Application (2011-2016)
Table United States Erythropoietin Drugs Sales Market Share by Application (2011-2016)
Figure United States Erythropoietin Drugs Sales Market Share by Application in 2015
Table United States Erythropoietin Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Erythropoietin Drugs Sales Growth Rate by Application (2011-2016)
Table Amgen Basic Information List
Table Amgen Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Erythropoietin Drugs Sales Market Share (2011-2016)
Table LG Life Sciences Basic Information List
Table LG Life Sciences Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table LG Life Sciences Erythropoietin Drugs Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Erythropoietin Drugs Sales Market Share (2011-2016)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyowa Hakko Kirin Erythropoietin Drugs Sales Market Share (2011-2016)
Table Shenyang 3SBio Inc. Basic Information List
Table Shenyang 3SBio Inc. Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shenyang 3SBio Inc. Erythropoietin Drugs Sales Market Share (2011-2016)
Table Shanghai Kirin Kunpeng Basic Information List
Table Shanghai Kirin Kunpeng Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai Kirin Kunpeng Erythropoietin Drugs Sales Market Share (2011-2016)
Table Beijing Four Rings Biopharmaceutical Basic Information List
Table Beijing Four Rings Biopharmaceutical Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Beijing Four Rings Biopharmaceutical Erythropoietin Drugs Sales Market Share (2011-2016)
Table Scipregen Basic Information List
Table Scipregen Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Scipregen Erythropoietin Drugs Sales Market Share (2011-2016)
Table Shandong Kexing Basic Information List
Table Shandong Kexing Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shandong Kexing Erythropoietin Drugs Sales Market Share (2011-2016)
Table Company ten Basic Information List
Table Company ten Erythropoietin Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Company ten Erythropoietin Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Erythropoietin Drugs
Figure Manufacturing Process Analysis of Erythropoietin Drugs
Figure Erythropoietin Drugs Industrial Chain Analysis
Table Raw Materials Sources of Erythropoietin Drugs Major Manufacturers in 2015
Table Major Buyers of Erythropoietin Drugs
Table Distributors/Traders List
Figure United States Erythropoietin Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Erythropoietin Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Erythropoietin Drugs Production Forecast by Type (2016-2021)
Table United States Erythropoietin Drugs Consumption Forecast by Application (2016-2021)